Results 281 to 290 of about 237,899 (303)
Some of the next articles are maybe not open access.
Managing diabetes with nanomedicine: challenges and opportunities
Nature Reviews Drug Discovery, 2014Omid Veiseh +2 more
exaly
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Nature Reviews Drug Discovery, 2016Kfir Sharabi, Pere Puigserver
exaly
Targeting adipose tissue in the treatment of obesity-associated diabetes
Nature Reviews Drug Discovery, 2016Perry E Bickel, Philipp Scherer
exaly
Targeting the pancreatic β-cell to treat diabetes
Nature Reviews Drug Discovery, 2014Amedeo Vetere +2 more
exaly
Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes
Nature Reviews Drug Discovery, 2011Frank D Waldron-Lynch, Kevan C Herold
exaly
Leptin revisited: its mechanism of action and potential for treating diabetes
Nature Reviews Drug Discovery, 2012Roberto Coppari
exaly
Type 2 diabetes as an inflammatory disease
Nature Reviews Immunology, 2011Marc Y Donath, Steven E Shoelson
exaly
mTOR: from growth signal integration to cancer, diabetes and ageing
Nature Reviews Molecular Cell Biology, 2010Roberto Zoncu +2 more
exaly
Engineering immunomodulatory biomaterials for type 1 diabetes
Nature Reviews Materials, 2019Cherie L Stabler, Ying Li
exaly
Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?
Nature Reviews Clinical Oncology, 2016Adi J Klil-Drori +2 more
exaly